Forsyth P - Search Results

1

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.

Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S. Horbinski C, et al. Among authors: forsyth p. J Natl Compr Canc Netw. 2023 Jan;21(1):12-20. doi: 10.6004/jnccn.2023.0002. J Natl Compr Canc Netw. 2023. PMID: 36634606

2

Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications.

Mitchell A, Scheithauer BW, Unni KK, Forsyth PJ, Wold LE, McGivney DJ. Mitchell A, et al. Among authors: forsyth pj. Cancer. 1993 Nov 15;72(10):2943-9. doi: 10.1002/1097-0142(19931115)72:10<2943::aid-cncr2820721014>3.0.co;2-6. Cancer. 1993. PMID: 7693324

3

Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.

Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD. Burton EC, et al. Among authors: forsyth p. Cancer Res. 2002 Nov 1;62(21):6205-10. Cancer Res. 2002. PMID: 12414648

4

Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.

Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD. Burton EC, et al. Among authors: forsyth p. Clin Cancer Res. 2002 Jan;8(1):180-7. Clin Cancer Res. 2002. PMID: 11801556

5

Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease: A Phase 1 Nonrandomized Controlled Trial.

Ahmed KA, Kumthekar PU, Pina Y, Kim Y, Vogelbaum MA, Han HS, Forsyth PA. Ahmed KA, et al. Among authors: forsyth pa. JAMA Oncol. 2024 May 23:e241299. doi: 10.1001/jamaoncol.2024.1299. Online ahead of print. JAMA Oncol. 2024. PMID: 38780965

6

Empowering European hospital pharmacists in the face of heart failure.

Defieuw L, Hias J, Karapinar-Carkıt F, Forsyth P, Van der Linden LR. Defieuw L, et al. Among authors: forsyth p. Eur J Hosp Pharm. 2024 May 13:ejhpharm-2023-004068. doi: 10.1136/ejhpharm-2023-004068. Online ahead of print. Eur J Hosp Pharm. 2024. PMID: 38740548 No abstract available.

7

Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone.

Mills MN, Uno A, Li P, Liveringhouse C, Kim Y, Oliver DE, Perez BA, Creelan BC, Yu M, Forsyth PA, Pina Y, Ahmed KA. Mills MN, et al. Among authors: forsyth pa. Clin Lung Cancer. 2024 Apr 10:S1525-7304(24)00048-2. doi: 10.1016/j.cllc.2024.04.005. Online ahead of print. Clin Lung Cancer. 2024. PMID: 38719648

8

Patient Experiences of Community Pharmacy Medication Supply and Medicines Reconciliation at Hospital Discharge: A Pilot Qualitative Study.

Mundell R, Jamieson D, Shaw G, Thomson A, Forsyth P. Mundell R, et al. Among authors: forsyth p. Pharmacy (Basel). 2024 Apr 10;12(2):66. doi: 10.3390/pharmacy12020066. Pharmacy (Basel). 2024. PMID: 38668092 Free PMC article.

9

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease.

Law V, Smalley I, Evernden BR, Baldwin M, Smalley KSM, Forsyth PA. Law V, et al. Among authors: forsyth pa. J Vis Exp. 2024 Mar 29;(205). doi: 10.3791/66071. J Vis Exp. 2024. PMID: 38619274

10

Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review.

Wallace G, Kundalia R, Vallebuona E, Cao B, Kim Y, Forsyth P, Soyano A, Smalley I, Pina Y. Wallace G, et al. Among authors: forsyth p. Breast Cancer Res. 2024 Mar 29;26(1):55. doi: 10.1186/s13058-024-01789-7. Breast Cancer Res. 2024. PMID: 38553702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

344 results

Search Page